Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.

Recent Articles By The Author

2 Candidates That Could Be the Next Biotech Rockets

2 Candidates That Could Be the Next Biotech Rockets

Omeros Corp. and EyePoint Pharmaceuticals each have promising treatments that could send their shares skyward.

Riding 2 Big Winners in Small Biotech

Riding 2 Big Winners in Small Biotech

Reata Pharmaceuticals and Axsome Therapeutics each have had a terrific 2019, which helps offset the losing bets in this high-beta sector of the market.

2 Beaten Down Stocks to Consider

2 Beaten Down Stocks to Consider

Keep an eye on Camping World Holdings and industrial packaging firm Greif.

Here Are Several Promising Rare Disease Stocks

Here Are Several Promising Rare Disease Stocks

These small biotech concerns are undervalued.

I'm Unapologetically Overweight in These 2 Sectors

I'm Unapologetically Overweight in These 2 Sectors

The two are homebuilding and biotech, and there are stocks within those sectors where I've parked my money.

Here's Why I'm Underweighting a Number of Market Sectors

Here's Why I'm Underweighting a Number of Market Sectors

Finding the right stocks is like finding the right dance partner.

Possible M&A Surrounds These 3 Stocks

Possible M&A Surrounds These 3 Stocks

M&A activity has generally slowed.

2 Sagging Stocks That Could Make Good Covered Call Plays

2 Sagging Stocks That Could Make Good Covered Call Plays

Camping World and American Airlines have had tough years but looks like call option candidates as their prospects improve.

3 Biotech Plays That Would Work as Covered Calls

3 Biotech Plays That Would Work as Covered Calls

The SPDR S&P Biotech ETF, Alexion Pharmaceuticals and BioMarin Pharmaceuticals set up nicely for this options strategy.

Markets Become Rocky, Especially for IPOs

Markets Become Rocky, Especially for IPOs

Cracks are appearing in some high-beta parts of the market, and a few recent initial public offerings have been pulled or haven't fared well after issuance.